Genzyme Molecular, Silico cancer deal

GZMO and Silico Insights (Woburn, Mass.) partnered to identify and characterize cancer pathways and targets, with an initial focus on breast cancer. The deal combines GZMO's Serial Analysis of Gene Ex...